FILIERI, Maria Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 576
EU - Europa 327
AS - Asia 90
AF - Africa 7
OC - Oceania 2
SA - Sud America 2
Totale 1.004
Nazione #
US - Stati Uniti d'America 572
GB - Regno Unito 105
IE - Irlanda 67
SE - Svezia 39
IT - Italia 37
CN - Cina 35
DE - Germania 35
UA - Ucraina 19
HK - Hong Kong 16
VN - Vietnam 9
FR - Francia 8
JP - Giappone 7
TR - Turchia 7
BG - Bulgaria 6
IN - India 6
CA - Canada 4
FI - Finlandia 4
TZ - Tanzania 4
AU - Australia 2
BE - Belgio 2
DK - Danimarca 2
ID - Indonesia 2
IR - Iran 2
MY - Malesia 2
NL - Olanda 2
UG - Uganda 2
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
IQ - Iraq 1
MA - Marocco 1
PK - Pakistan 1
SG - Singapore 1
TH - Thailandia 1
Totale 1.004
Città #
Southend 72
Dublin 67
Chandler 64
Ashburn 63
Fairfield 60
Dearborn 39
Woodbridge 39
Houston 36
Nyköping 33
Wilmington 32
Seattle 29
Jacksonville 28
Cambridge 26
Ann Arbor 20
Hong Kong 14
New York 14
Beijing 13
Fremont 9
Dong Ket 7
Eugene 6
Princeton 6
San Diego 6
Shanghai 6
Sofia 6
Falls Church 5
Leicester 5
Guangzhou 4
Helsinki 4
Izmir 4
London 4
Modena 4
Bremen 3
Bedizzole 2
Brussels 2
Hanoi 2
Horsens 2
Kunming 2
Los Angeles 2
Mumbai 2
Nanjing 2
Napoli 2
Ottawa 2
Phoenix 2
Québec 2
Redwood City 2
Rome 2
San Mateo 2
Tehran 2
Tokyo 2
Ankara 1
Atlanta 1
Baghdad 1
Bangkok 1
Berlin 1
Bologna 1
Central District 1
Chicago 1
Costa Mesa 1
Dar es Salaam 1
Dundee 1
Groningen 1
Hebei 1
Hefei 1
Islington 1
Jakarta 1
Kilburn 1
L'aquila 1
Lausanne 1
Milan 1
Mountain View 1
Nanchang 1
Norwalk 1
Nürnberg 1
Perth 1
Piacenza 1
Pune 1
Rawalpindi 1
Reno 1
Richmond 1
Riverwood 1
Rubiera 1
Salé 1
Shenyang 1
Singapore 1
St Louis 1
Trieste 1
Weissach 1
Xian 1
Zhengzhou 1
Totale 802
Nome #
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 211
Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer. 184
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 175
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 167
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 144
Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer. 133
Totale 1.014
Categoria #
all - tutte 3.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201963 0 0 0 0 0 0 0 0 0 9 24 30
2019/2020201 22 4 8 18 25 30 39 13 18 9 13 2
2020/2021184 22 6 13 6 27 13 14 32 10 13 12 16
2021/2022120 1 13 3 4 7 12 3 5 14 10 27 21
2022/2023238 24 27 15 17 16 15 6 16 84 4 5 9
2023/202493 1 6 7 11 14 8 10 31 1 4 0 0
Totale 1.014